KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Accumulated Expenses (2016 - 2025)

Historic Accumulated Expenses for Eli Lilly (LLY) over the last 17 years, with Q3 2025 value amounting to $2.0 billion.

  • Eli Lilly's Accumulated Expenses rose 1540.54% to $2.0 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 billion, marking a year-over-year increase of 1540.54%. This contributed to the annual value of $2.1 billion for FY2024, which is 2687.23% up from last year.
  • According to the latest figures from Q3 2025, Eli Lilly's Accumulated Expenses is $2.0 billion, which was up 1540.54% from $1.3 billion recorded in Q2 2025.
  • In the past 5 years, Eli Lilly's Accumulated Expenses ranged from a high of $2.1 billion in Q4 2024 and a low of $649.9 million during Q1 2021
  • Its 5-year average for Accumulated Expenses is $1.1 billion, with a median of $984.1 million in 2022.
  • In the last 5 years, Eli Lilly's Accumulated Expenses plummeted by 392.1% in 2021 and then surged by 5572.75% in 2023.
  • Quarter analysis of 5 years shows Eli Lilly's Accumulated Expenses stood at $958.1 million in 2021, then rose by 10.61% to $1.1 billion in 2022, then surged by 55.73% to $1.7 billion in 2023, then grew by 26.87% to $2.1 billion in 2024, then fell by 6.12% to $2.0 billion in 2025.
  • Its last three reported values are $2.0 billion in Q3 2025, $1.3 billion for Q2 2025, and $1.1 billion during Q1 2025.